Skip to main content
Veterinary Medicines

MASTIJET FORTE

Authorised
  • Bacitracin
  • NEOMYCIN SULFATE
  • Tetracycline hydrochloride
  • Prednisolone

Product identification

Medicine name:
MASTIJET FORTE
Active substance:
  • Bacitracin
  • NEOMYCIN SULFATE
  • Tetracycline hydrochloride
  • Prednisolone
Target species:
  • Cattle (lactating cow)
Route of administration:
  • Intramammary use

Product details

Active substance and strength:
  • Bacitracin
    2000.00
    international unit(s)
    /
    1.00
    Syringe
  • NEOMYCIN SULFATE
    250.00
    milligram(s)
    /
    1.00
    Syringe
  • Tetracycline hydrochloride
    200.00
    milligram(s)
    /
    1.00
    Syringe
  • Prednisolone
    10.00
    milligram(s)
    /
    1.00
    Syringe
Pharmaceutical form:
  • Intramammary suspension
Withdrawal period by route of administration:
  • Intramammary use
    • Cattle (lactating cow)
      • Meat and offal
        14
        day
      • Milk
        8
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ51RV01
Authorisation status:
  • Valid
Authorised in:
  • Romania
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • INTERVET INTERNATIONAL B.V.
Responsible authority:
  • Institute For Control Of Biological Products And Veterinary Medicines
Authorisation number:
  • 110255
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Romanian (PDF)
Published on: 7/03/2024
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."